We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
-4.22%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$16.9B
AUM Growth
-$2.13B
Cap. Flow
-$1.02B
Cap. Flow %
-6.06%
Top 10 Hldgs %
39.23%
Holding
1,372
New
74
Increased
459
Reduced
680
Closed
155

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$138M
2
NVDA icon
NVIDIA
NVDA
+$69.6M
3
SYNA icon
Synaptics
SYNA
+$37.7M
4
MCHP icon
Microchip Technology
MCHP
+$29.7M
5
LRCX icon
Lam Research
LRCX
+$24.5M

Sector Composition

Rank Sector Weight
1 Technology 36.16%
2 Financials 15.03%
3 Energy 6.15%
4 Healthcare 5.33%
5 Consumer Discretionary 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADVM
1201
DELISTED
Adverum Biotechnologies
ADVM
$59K ﹤0.01%
4,488
-423
-9% -$6.19K
UAVS icon
1202
AgEagle Aerial Systems
UAVS
$42.1M
$59K ﹤0.01%
50
+15
+43% +$17.7K
HOFV
1203
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$55K ﹤0.01%
2,235
+406
+22% +$10.4K
GPUS
1204
Hyperscale Data Inc
GPUS
$56.5M
0
BNGO icon
1205
Bionano Genomics
BNGO
$12.7M
$54K ﹤0.01%
35
+12
+52% +$16.2K
HIVE
1206
HIVE Digital Technologies
HIVE
$791M
$49K ﹤0.01%
+4,648
New +$47.8K
LOTZ
1207
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$47K ﹤0.01%
34,454
+6,356
+23% +$12K
SHCR
1208
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$46K ﹤0.01%
+18,501
New +$60.8K
ATNX
1209
DELISTED
Athenex, Inc. Common Stock
ATNX
$46K ﹤0.01%
2,752
+931
+51% +$18.2K
SEEL
1210
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$43K ﹤0.01%
13
+1
+8% +$4.3K
USX
1211
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$41K ﹤0.01%
+10,614
New +$47.6K
VEON icon
1212
VEON
VEON
$3.68B
$35K ﹤0.01%
2,035
-4
-0.2% -$109
REE
1213
DELISTED
REE Automotive
REE
$30K ﹤0.01%
523
-239
-31% -$24.4K
GOCO
1214
DELISTED
GoHealth
GOCO
$28K ﹤0.01%
1,608
-78
-5% -$2.43K
RNAC icon
1215
Cartesian Therapeutics
RNAC
$231M
$19K ﹤0.01%
512
+34
+7% +$2.13K
SRGA
1216
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$12K ﹤0.01%
1,261
-741
-37% -$11.3K
MTNB icon
1217
Matinas BioPharma
MTNB
$1.93M
$10K ﹤0.01%
257
-431
-63% -$15.9K
ADC icon
1218
Agree Realty
ADC
$9.57B
-3,700
Closed -$264K
ALDX icon
1219
Aldeyra Therapeutics
ALDX
$92.3M
-212,975
Closed -$852K
ALLK
1220
DELISTED
Allakos
ALLK
-72,436
Closed -$709K
ALT icon
1221
Altimmune
ALT
$583M
-362,943
Closed -$3.33M
AMH icon
1222
American Homes 4 Rent
AMH
$12.4B
-15,569
Closed -$679K
ANNX icon
1223
Annexon
ANNX
$860M
-71,681
Closed -$824K
BARK icon
1224
BARK
BARK
$88.8M
-9,965
Closed -$841K
BCAB icon
1225
BioAtla
BCAB
$5.41M
-1,662
Closed -$1.63M

Similar funds

Rafferty Asset Management's Q1 2022 Portfolio in Review

As of Q1 2022, Rafferty Asset Management held 1,372 positions worth $16.9B, down 11% from $19B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Rafferty Asset Management withdrew a net $1.02B in Q1 2022, closing 155 positions and reducing 680 holdings. Its most notable exit was Xilinx Inc, an estimated $169M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Energy.

Against the trend, Rafferty Asset Management opened a new position in Synaptics worth $33.9M.

  • Rafferty Asset Management's largest Q1 2022 buy was Synaptics: 170,061 shares worth $33.9M.
  • Rafferty Asset Management added most to Advanced Micro Devices in Q1 2022, an estimated $138M increase.
  • Rafferty Asset Management's biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $184M.
  • Rafferty Asset Management fully exited Xilinx Inc in Q1 2022, selling an estimated $169M.
  • Rafferty Asset Management's ten largest holdings make up 39% of its $16.9B portfolio in Q1 2022.
  • Rafferty Asset Management opened 74 new positions and closed 155 in Q1 2022.
  • Rafferty Asset Management's portfolio value fell 11% quarter-over-quarter to $16.9B.

Based on Rafferty Asset Management's 13F filing for Q1 2022, filed 13 May 2022.